New pill aims to fight stubborn lung cancer with STK11 mutation
Disease control
Recruiting now
This study tests an experimental drug called JBI-802, taken as a pill, alone or with another drug (pembrolizumab), in people with advanced lung cancer that has a specific gene change (STK11 mutation). The goal is to see if the treatment is safe and helps shrink or control the can…
Phase: PHASE2 • Sponsor: The Christ Hospital • Aim: Disease control
Last updated May 14, 2026 12:05 UTC